Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues

PURPOSE OF THE REVIEW: As the number of cancer survivors increases due to early screening and modern (antineoplastic) treatments, cancer treatment associated cardiotoxicity (CTAC) is becoming an increasing health burden that affects survival and quality of life among cancer survivors. Thus, clinicia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bracun, Valentina, Aboumsallem, Joseph Pierre, van der Meer, Peter, de Boer, Rudolf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Cardio-oncology (EH Yang, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280346/
https://www.ncbi.nlm.nih.gov/pubmed/32514994
http://dx.doi.org/10.1007/s11912-020-00930-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280346/
https://www.ncbi.nlm.nih.gov/pubmed/32514994
http://dx.doi.org/10.1007/s11912-020-00930-x

Ejemplares similares